| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 449 | 11.179 | - | 10.586 | 10.089 | - | 10.537 | 84.364 |
| Total Income - EUR | - | 0 | 449 | 11.179 | - | 10.586 | 10.089 | - | 10.537 | 84.364 |
| Total Expenses - EUR | - | 0 | 1.943 | 9.822 | - | 5.540 | 11.616 | - | 12.350 | 30.457 |
| Gross Profit/Loss - EUR | - | 0 | -1.494 | 1.357 | - | 5.046 | -1.527 | - | -1.813 | 53.906 |
| Net Profit/Loss - EUR | - | 0 | -1.508 | 1.245 | - | 4.940 | -1.626 | - | -1.916 | 51.426 |
| Employees | - | 0 | 1 | 1 | - | 1 | 1 | - | 1 | 2 |
Check the financial reports for the company - Erenamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | - | 0 | 0 | - | 0 | 0 |
| Current Assets | - | 0 | 437 | 8.862 | - | 18.013 | 16.684 | - | 9.078 | 52.939 |
| Inventories | - | 0 | 105 | 103 | - | 99 | 97 | - | 97 | 1.423 |
| Receivables | - | 0 | 0 | 5.074 | - | -103 | 2.790 | - | 3.290 | 29.874 |
| Cash | - | 0 | 332 | 3.686 | - | 18.017 | 13.797 | - | 5.691 | 21.643 |
| Shareholders Funds | - | 0 | -2.902 | -1.604 | - | 9.962 | 8.116 | - | 7.378 | 49.717 |
| Social Capital | - | 0 | 44 | 43 | - | 41 | 40 | - | 40 | 40 |
| Debts | - | 0 | 3.339 | 10.466 | - | 8.050 | 8.568 | - | 1.700 | 3.223 |
| Income in Advance | - | 0 | 0 | 0 | - | 0 | 0 | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Erenamed Srl